CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Delirium Abatement Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00182936
NCT00182936Phase 3Completed
CompareCT.gov

A Trial to Reduce Delirium in Aged Post Acute Patients

National Institute on Aging (NIA)·interventional·Posted Sep 16, 2005·Updated Nov 20, 2006

In Brief

A Phase 3 clinical trial evaluating Delirium Abatement Program for Delirium and Aging. Completed, across 1 site.

Detailed Summary

The purpose of this study is to develop a comprehensive Delirium Abatement Program of care of delirious patients in the post acute care setting and to evaluate its impact on persistence and severity of delirium and on functional recovery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelirium, Aging
CountriesUnited States
CollaboratorsPaul B. Beeson Career Development Awards in Aging Research Program

Timeline

Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartMay 1, 2000
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Delirium Abatement Programbehavioral